PepsiCo, Biocon to set up facilities in Karnataka

The Karnataka government on Wednesday approved three projects, including that of PepsiCo India and Biocon, committing total investment of Rs 2,211 crore.

Biotechnology major Biocon has proposed an investment of Rs 1,060 crore for the manufacture of injectables, monoclonal and anti-bodies vaccine at Anekal taluk. It is expected to employ about 750 people, an official release said.

PepsiCo India Holdings Pvt Ltd proposes to set up beverages and snacks manufacturing unit with an investment of Rs 590 crore, employing 900 people, at Nanjangud taluk in Mysuru district.

The 44th state high level clearance committee meeting, chaired by Chief Minister Siddaramaiah also approved one expansion project proposal of Manyata Promoters Pvt Ltd, with an additional investment of Rs 561 crore, which generates additional employment to about 7,170 people.

With an investment of Rs 561 crore Manyata will develop Information Technology Park and allied infrastructure; hotel, convention centre, retail and commercial space at Nagavara, Rachenahalli and Thannisandra villages in Bengaluru.